FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes

Objectives. Gestational diabetes mellitus (GDM) is glucose intolerance detected initially during pregnancy. GDM poses an increased risk for the development of diabetes later in life. Fatty acid-binding protein 4 (FABP4) is a regulator of lipid metabolism and is associated with obesity, insulin resis...

Full description

Saved in:
Bibliographic Details
Main Authors: Tamara Vorobjova, Aili Tagoma, Ija Talja, Helis Janson, Anne Kirss, Raivo Uibo
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2022/1089434
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832565335140597760
author Tamara Vorobjova
Aili Tagoma
Ija Talja
Helis Janson
Anne Kirss
Raivo Uibo
author_facet Tamara Vorobjova
Aili Tagoma
Ija Talja
Helis Janson
Anne Kirss
Raivo Uibo
author_sort Tamara Vorobjova
collection DOAJ
description Objectives. Gestational diabetes mellitus (GDM) is glucose intolerance detected initially during pregnancy. GDM poses an increased risk for the development of diabetes later in life. Fatty acid-binding protein 4 (FABP4) is a regulator of lipid metabolism and is associated with obesity, insulin resistance, and type 2 diabetes. Increased level of intestinal fatty acid-binding protein (I-FABP) may indicate impaired intestinal permeability, which may be an important contributor to the pathogenesis of type 1 diabetes and GDM. We aimed to compare FABP4 and I-FABP levels in pregnant women with GDM and in healthy pregnant controls, taking into consideration their prepregnancy body mass index (BMI), past exposures to enteroviruses (EV), and adipokine and cytokine levels, which have been shown to decrease insulin sensitivity. Material and Methods. Forty patients with GDM (median age 30.5) and 40 pregnant healthy controls (median age 31.1) were divided on the basis of their prepregnancy BMI into two groups: normal weight (BMI<25, n=20) and overweight (BMI≥25, n=20). FABP4 and I-FABP were measured from serum samples using commercial ELISA kits. Results. FABP4 and I-FABP levels did not differ between women with GDM and healthy pregnant controls (p>0.05 for both comparisons). However, both levels were associated with BMI (p<0.001 for both comparisons). Median I-FABP level was the highest in healthy controls with lower BMI (<25) (p=0.0009). FABP4 levels correlated with BMI and C-peptide values in both groups (p<0.001). Anti-EV antibody levels did not correlate with FABP4 or I-FABP levels. FABP4 and adiponectin levels were negatively correlated in controls (r=−0.61, p=0.0009), while I-FABP correlated positively with adiponectin (r=0.58, p=0.04) and resistin (r=0.67, p=0.04) levels in the GDM group. Conclusion. FABP4 and I-FABP levels were not dependent on the diagnosis of GDM, but rather on BMI. The correlation of I-FABP with adiponectin and resistin levels in women with GDM may suggests the importance of lipid metabolism in GDM-associated changes in intestinal permeability.
format Article
id doaj-art-d8c4a4e2830a4d34acbd9dcddbce25e5
institution Kabale University
issn 2314-6753
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-d8c4a4e2830a4d34acbd9dcddbce25e52025-02-03T01:08:45ZengWileyJournal of Diabetes Research2314-67532022-01-01202210.1155/2022/1089434FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational DiabetesTamara Vorobjova0Aili Tagoma1Ija Talja2Helis Janson3Anne Kirss4Raivo Uibo5Department of ImmunologyDepartment of ImmunologyDepartment of ImmunologyDepartment of ImmunologyWomen’s ClinicDepartment of ImmunologyObjectives. Gestational diabetes mellitus (GDM) is glucose intolerance detected initially during pregnancy. GDM poses an increased risk for the development of diabetes later in life. Fatty acid-binding protein 4 (FABP4) is a regulator of lipid metabolism and is associated with obesity, insulin resistance, and type 2 diabetes. Increased level of intestinal fatty acid-binding protein (I-FABP) may indicate impaired intestinal permeability, which may be an important contributor to the pathogenesis of type 1 diabetes and GDM. We aimed to compare FABP4 and I-FABP levels in pregnant women with GDM and in healthy pregnant controls, taking into consideration their prepregnancy body mass index (BMI), past exposures to enteroviruses (EV), and adipokine and cytokine levels, which have been shown to decrease insulin sensitivity. Material and Methods. Forty patients with GDM (median age 30.5) and 40 pregnant healthy controls (median age 31.1) were divided on the basis of their prepregnancy BMI into two groups: normal weight (BMI<25, n=20) and overweight (BMI≥25, n=20). FABP4 and I-FABP were measured from serum samples using commercial ELISA kits. Results. FABP4 and I-FABP levels did not differ between women with GDM and healthy pregnant controls (p>0.05 for both comparisons). However, both levels were associated with BMI (p<0.001 for both comparisons). Median I-FABP level was the highest in healthy controls with lower BMI (<25) (p=0.0009). FABP4 levels correlated with BMI and C-peptide values in both groups (p<0.001). Anti-EV antibody levels did not correlate with FABP4 or I-FABP levels. FABP4 and adiponectin levels were negatively correlated in controls (r=−0.61, p=0.0009), while I-FABP correlated positively with adiponectin (r=0.58, p=0.04) and resistin (r=0.67, p=0.04) levels in the GDM group. Conclusion. FABP4 and I-FABP levels were not dependent on the diagnosis of GDM, but rather on BMI. The correlation of I-FABP with adiponectin and resistin levels in women with GDM may suggests the importance of lipid metabolism in GDM-associated changes in intestinal permeability.http://dx.doi.org/10.1155/2022/1089434
spellingShingle Tamara Vorobjova
Aili Tagoma
Ija Talja
Helis Janson
Anne Kirss
Raivo Uibo
FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes
Journal of Diabetes Research
title FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes
title_full FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes
title_fullStr FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes
title_full_unstemmed FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes
title_short FABP4 and I-FABP Levels in Pregnant Women Are Associated with Body Mass Index but Not Gestational Diabetes
title_sort fabp4 and i fabp levels in pregnant women are associated with body mass index but not gestational diabetes
url http://dx.doi.org/10.1155/2022/1089434
work_keys_str_mv AT tamaravorobjova fabp4andifabplevelsinpregnantwomenareassociatedwithbodymassindexbutnotgestationaldiabetes
AT ailitagoma fabp4andifabplevelsinpregnantwomenareassociatedwithbodymassindexbutnotgestationaldiabetes
AT ijatalja fabp4andifabplevelsinpregnantwomenareassociatedwithbodymassindexbutnotgestationaldiabetes
AT helisjanson fabp4andifabplevelsinpregnantwomenareassociatedwithbodymassindexbutnotgestationaldiabetes
AT annekirss fabp4andifabplevelsinpregnantwomenareassociatedwithbodymassindexbutnotgestationaldiabetes
AT raivouibo fabp4andifabplevelsinpregnantwomenareassociatedwithbodymassindexbutnotgestationaldiabetes